0001601485 2026-02-27 2026-02-27 0001601485 1 2026-02-27 2026-02-27 0001601485 2 2026-02-27 2026-02-27 0001601485 3 2026-02-27 2026-02-27 0001601485 4 2026-02-27 2026-02-27 0001601485 5 2026-02-27 2026-02-27 0001601485 6 2026-02-27 2026-02-27 iso4217:USD pure S-3 S-3 EX-FILING FEES 0001601485 Elicio Therapeutics, Inc. N/A N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 S-3 Elicio Therapeutics, Inc. Equity Common stock, $0.01 par value per share true Equity Preferred stock, $0.01 par value per share true Debt Debt Securities true Equity Warrants true Equity Units true false Unallocated (Universal) Shelf true 400000000.00 0.0001381 55240.00 400000000.00 55240.00 0.00 0.00 55240.00 Note 1. A. Security Type and Amount Registered - There are being registered hereunder such indeterminate number of shares of common stock and preferred stock, such indeterminate number of warrants to purchase common stock, preferred stock or debt securities, and such indeterminate principal amount of debt securities as shall have an aggregate initial offering price not to exceed $400,000,000. If any debt securities are issued at an original issued discount, then the offering price of such debt securities shall be in such greater principal amount as shall result in an aggregate initial offering price not to exceed $400,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. The securities registered also include such indeterminate amounts and numbers of common stock, preferred stock, and debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the anti-dilution provisions of any such securities. B. Proposed Maximum Offering Price Per Unit - The proposed maximum per unit and aggregate offering prices per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder. C. Security Type - Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. In no event will the aggregate offering price of all securities sold by the registrant from time to time pursuant to this registration statement exceed $400,000,000.